Literature DB >> 19519359

Novel tyrosine kinase inhibitors in the treatment of cancer.

Alberto Ocana1, Rosario Serrano, Raul Calero, Atanasio Pandiella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19519359     DOI： 10.2174/138945009788488378

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN： 1389-4501            Impact factor:   3.465


× No keyword cloud information.
  3 in total

Review 1.  Preclinical development of molecular-targeted agents for cancer.

Authors:  Alberto Ocana; Atanasio Pandiella; Lillian L Siu; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2010-12-07       Impact factor: 66.675

2.  Sunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesis.

Authors:  Raul Calero; Esther Morchon; John Inge Johnsen; Rosario Serrano
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

3.  Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening.

Authors:  Jian Liu; Yu Wen; Lina Gao; Liang Gao; Fengjun He; Jingxian Zhou; Junwei Wang; Rupeng Dai; Xiaojing Chen; Di Kang; Lihong Hu
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.